CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Large Decrease in Short Interest

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 1,045 shares, a drop of 50.6% from the January 29th total of 2,116 shares. Based on an average trading volume of 112 shares, the days-to-cover ratio is presently 9.3 days. Based on an average trading volume of 112 shares, the days-to-cover ratio is presently 9.3 days.

CellaVision AB (publ) Price Performance

Shares of OTCMKTS:CLVSF opened at $15.85 on Friday. CellaVision AB has a 52-week low of $16.69 and a 52-week high of $17.30. The business’s 50 day moving average is $16.66 and its 200 day moving average is $17.87.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.